{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:42Z","timestamp":1786984362359,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010544","name":"Exelixis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018488","name":"Clinical and Translational Science Institute, University of Florida","doi-asserted-by":"publisher","award":["TL1 TR001871"],"award-info":[{"award-number":["TL1 TR001871"]}],"id":[{"id":"10.13039\/100018488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018488","name":"Clinical and Translational Science Institute, University of Florida","doi-asserted-by":"publisher","award":["UL1 TR991872"],"award-info":[{"award-number":["UL1 TR991872"]}],"id":[{"id":"10.13039\/100018488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.amjmed.2021.07.041","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T02:37:53Z","timestamp":1631155073000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-9401","authenticated-orcid":false,"given":"Patricia C.","family":"Conroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-2672","authenticated-orcid":false,"given":"Sophia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-2384","authenticated-orcid":false,"given":"Claire E.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Chomsky-Higgins","family":"Menut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2355-2943","authenticated-orcid":false,"given":"Sarah","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chienying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen T.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gosnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3356-7316","authenticated-orcid":false,"given":"Julie A.","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanziana","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yang","family":"Duh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insoo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2021.07.041_bib0001","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1378\/chest.125.1.112","article-title":"Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea","volume":"125","author":"Calhoun","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2021.07.041_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jss.2018.10.040","article-title":"Treatment of primary aldosteronism reduces the probability of obstructive sleep apnea","volume":"236","author":"Wang","year":"2019","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.amjmed.2021.07.041_bib0003","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J Hum Hypertens"},{"issue":"9628","key":"10.1016\/j.amjmed.2021.07.041_bib0004","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2021.07.041_bib0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.amjmed.2021.07.041_bib0006","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.amjmed.2021.07.041_bib0007","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HJH.0b013e3283492219","article-title":"Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population","volume":"29","author":"Sim","year":"2011","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.041_bib0008","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.27878","article-title":"Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension","volume":"6","author":"Gonzaga","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.041_bib0009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/jhh.2017.28","article-title":"Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea","volume":"31","author":"Wolley","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.amjmed.2021.07.041_bib0010","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.amjmed.2021.07.041_bib0011","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.amjmed.2021.07.041_bib0012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"14","key":"10.1016\/j.amjmed.2021.07.041_bib0013","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.amjmed.2021.07.041_bib0014","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.041_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.amjmed.2021.07.041_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008888","article-title":"Trends in prevalence and control of hypertension according to the 2017 American College of Cardiology\/American Heart Association (ACC\/AHA) guideline","volume":"7","author":"Dorans","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.041_bib0017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5664\/jcsm.8960","article-title":"Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea","volume":"17","author":"Dobrowolski","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.041_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pcad.2008.08.001","article-title":"Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration","volume":"51","author":"Al Lawati","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.041_bib0019","first-page":"e10424","article-title":"Obstructive sleep apnea and cardiovascular morbidities: a review article","volume":"12","author":"Rana","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.041_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.041_bib0021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.041_bib0022","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11886-019-1185-x","article-title":"Primary aldosteronism: cardiovascular outcomes pre- and post-treatment","volume":"21","author":"Hundemer","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.1016\/j.amjmed.2021.07.041_bib0023","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1606599","article-title":"CPAP for prevention of cardiovascular events in obstructive sleep apnea","volume":"375","author":"McEvoy","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.041_bib0024","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","article-title":"Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives","volume":"165","author":"Ruhle","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.041_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.surg.2019.05.087","article-title":"Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system","volume":"167","author":"Sivarajah","year":"2020","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.041_bib0026","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/jamainternmed.2019.1747","article-title":"Diagnosis and management of primary hyperparathyroidism across the veterans affairs health care system","volume":"179","author":"Alore","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.041_bib0027","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamasurg.2020.2423","article-title":"Analysis of primary hyperparathyroidism screening among US veterans with kidney stones","volume":"155","author":"Ganesan","year":"2020","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.041_bib0028","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/SLA.0000000000002370","article-title":"Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure","volume":"266","author":"Balentine","year":"2017","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.amjmed.2021.07.041_bib0029","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"J Hypertens"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321005593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321005593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:17Z","timestamp":1762079417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934321005593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0002934321005593"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.07.041","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}